A candidate tetravalent dengue vaccine is being assessed in three clinical trials involving more than 35,000 children between the ages of 2 and 16 years in Asian–Pacific and Latin American countries. The researchers report the results of long-term follow-up interim analyses and integrated efficacy analyses.
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/efficacy-and-long-term-safety-dengue-vaccine-regions-endemic-disease
[2] http://admin.indiaenvironmentportal.org.in/category/author/s-r-hadinegoro
[3] http://admin.indiaenvironmentportal.org.in/category/author/j-l-arredondo-garc%C3%ADa
[4] http://admin.indiaenvironmentportal.org.in/category/author/m-r-capeding-et-al
[5] http://admin.indiaenvironmentportal.org.in/category/journal/new-england-journal-medicine
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/dengue
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vector-borne-diseases
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vector-control
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/child-health
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/who
[13] http://admin.indiaenvironmentportal.org.in/category/thesaurus/asia
[14] http://admin.indiaenvironmentportal.org.in/category/thesaurus/south-america
[15] http://admin.indiaenvironmentportal.org.in/category/thesaurus/thailand